New tumor markers of testis cancer

Urologic Clinics of North America

Volumn 25, Issue 3, 1998, Pages 365-373

  Dean, R C ^a   Moul, J W ^a  

^a Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CHROMOSOME MARKER; CYTOGENETICS; HUMAN; MALE; ONCOGENE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TESTIS CANCER; TUMOR SUPPRESSOR GENE;

EID: 0031880271     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70027-6     Document Type: Article

References (83)

1. P. Albers E. Bierhoff D. Neu MIB-1 Immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis Cancer 79 1997 1710
2. P. Albers G.A. Miller A. Orazi Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis Cancer 75 1995 844
3. E. Allhoff C. Wittekind S. Liedke The modular image analysis computer for assessment of prognosis in testicular tumors Verh Dtsch Ges Pathol 74 1990 196
4. N.B. Atkin M.C. Baker Specific chromosome change, i(12p) in testicular tumors? Lancet 2 1982 1349
5. M. Barbacid ras oncogenes: Their role in neoplasia Eur J Clin Invest 20 1990 225
6. J. Bartkova J. Bartek J. Lukas p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia Int J Cancer 49 1991 196
7. C. Bokemeyer M.A. Kuczyk T. Dunn Expression of stem-cell factor and its receptor c- kit protein in normal testicular tissue and malignant germ-cell tumors J Cancer Res Clin Oncol 122 1996 301
8. J.L. Bos ras oncogenes in human cancer: A review Cancer Res 49 1989 4682
9. G.J. Bosl E. Dimitrovsky V.E. Reuter Isochromosome of chromosome 12: Clinically useful marker for male germ cell tumors J Natl Cancer Inst 81 1989 1874
10. R.A. Burger U. Witzsch H. Engel Automated image analysis DNA cytometry in testicular cancer Urol Res 22 1994 17
11. T.W. DeGraaf S. DeJong E.G.E. De Vries N.H. Mulder Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer Anticancer Res 17 1997 369
12. W.T. DeRiese P. Albers E.B. Walker Predictive parameters of biologic behavior of early stage nonseminomatous germ cell tumors Cancer 74 1994 1335
13. W.T. DeRiese A. Orazi R.S. Foster The clinical relevance of p53 expression in early stage nonseminomatous germ cell tumor J Urol 149 1993 311A
14. K. Dorfinger C. Kratzik S. Madersbacher Tumor markers in hydrocele fluids of patients with benign and malignant scrotal disease J Urol 158 1997 851
15. L.H. Einhorn Treatment of testicular cancer: A new and improved model J Clin Oncol 8 11 1990 1777 1781
16. A.G. Eliopoulos D.J. Kerr J. Herod The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and bcl-2 Oncogene 11 1995 1217
17. F.E. von Eyben W.E. de Graaff J. Marrink Serum lactate dehydrogenase isoenzyme 1 activity in patients with testicular germ cell tumors correlates with the total number of copies of the short arm of chromosome 12 in the tumor Mol Gen Genet 235 1992 140
18. E.B. Fernandez I. Sesterhenn W.F. McCarthy Proliferating cell nuclear antigen expression to predict occult disease in clinical stage I nonseminomatous germ cell tumors J Urol 152 1994 1133
19. M. Fleischhacker T. Strohmeyer Y. Imai Mutations of the p53 gene are not detectable in human testicular tumors Mod Pathol 7 1994 435
20. S.D. Fossa O. Klepp E. Paus Neuron-specific enolase: A serum tumour marker in seminoma? Br J Cancer 65 1992 297
21. S. Fossa J.M. Nesland H. Waehre DNA ploidy in the primary testicular cancer Br J Cancer 64 1991 948
22. S. Ganguly V.V.V.S. Murty F. Samaniego Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction Genes Chromosom Cancer 1 1990 228
23. R.L. Garcia M.D. Coltera A.M. Gown Analysis of proliferative anti-PCNA-cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis Am J Pathol 134 1989 733
24. M. Gregoire W.M. Schopperle W.C. DeWolf Distinct glycoforms of a tumor specific glycoprotein, gp 200, in human testis and testicular tumors J Urol 154 1995 275
25. A.J. Gross K.P. Dieckmann Neuron-specific enolase: A serum tumor marker in malignant germ-cell tumors? Eur Urol 24 1993 277
26. E. Hanna I. Godrogi E. Institoris M. Bak Correlation between p53 expression and clinical resistance in testicular cancer Orv Hetil 137 1996 59
27. A. Heidenreich J. Gadipatti J.W. Moul S. Srivastava Mutations of the tumor suppressor genes p15 and p16 are rare in human testicular germ cell tumors [abstract #4024] Proc Am Ass Cancer Res 37 1996 586
28. A. Heidenreich N. Schenkman I.A. Sesterhenn Immunohistochemical and mutational analysis of the p53 tumor suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumors Acta Pathologica et Microbiologica Scandinaviae, APMIS 106 1 1998 90 99
29. Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW: Prognostic risk factors in clinical stage I nonseminomatous germ cell tumors [abstract 234]. XIIth Congress of the European Association of Urology. Paris, September 1–4, 1996
30. A. Heidenreich I.A. Sesterhenn J.W. Moul Prognostic risk factors in low stage testicular germ cell tumors Cancer 79 1997 1641
31. A. Heidenreich J. Zumbe T.H. Klotz U.H. Engelman Diagnosis and follow-up of testicular carcinoma in situ by DNA image cytometry Eur Urol 28 1995 13
32. M. Hollstein D. Sidransky B. Vogelstein C.C. Harris p53 mutations in human cancers Science 253 1991 49
33. G. Kessel van R.F. Suijkerbuijk R.J. Sinke Molecular cytogenetics of human germ cell tumors: i(12p) and related chromosomal anomalies Eur Urol 23 1993 23
34. H. Kinumaki H. Takeuchi K. Nakamura Serum lactate dehydrogenase isoenzyme-1 in children with yolk sac tumor Cancer 56 1985 178
35. H.S. Klys D. Whillis G. Howard D.J. Harrison Glutathione S-transferase expression in human testis and testicular germ cell neoplasia Br J Cancer 66 1992 589
36. K. Koshida A. Nishino H. Yamamoto The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors J Urol 146 1991 57
37. P.H. Lange J.L. Millan T. Stigbrand Placental alkaline phosphatase as a tumour marker for seminoma Cancer Res 42 1982 3244
38. D.J. Lewis I.A. Sesterhenn W.F. McCarthy J.W. Moul Immunohistochemical expression of p53 tumor suppressor gene protein in adult germ cell testis tumors: Clinical correlation in stage I disease J Urol 152 1994 418
39. R.A. Lothe P. Peltomäki N. Tommerup Molecular genetic changes in human male germ cell tumors Lab Invest 73 1995 606
40. M.D. Mason M.F. Pera S. Cooper Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours Eur J Cancer 27 1991 300
41. F.K. Mostofi Pathology of germ cell tumors of testis. A progress report Cancer 45 1980 1735
42. F.K. Mostofi E.R. Price Jr Tumors of the male genital system. Atlas of Tumor Pathology series 2 1973 Armed Forces Institute of Pathology Washington, DC
43. J.W. Moul J.P. Foley C.L. Hitchcock Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular germ cell tumors J Urol 150 1993 879
44. J.W. Moul W.F. McCarthy E.B. Fernandez I.A. Sesterhenn Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer Cancer Res 54 1994 362
45. J.W. Moul P.B. Snow E.B. Fernandez Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer J Urol 153 1995 1674
46. J.W. Moul S. Theune E.H. Chang Detection of ras mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization Genes Chromosom Cancer 5 1992 109
47. H.A. Muensch W.C. Maslow F. Azama Placental-like alkaline phosphatase: Re-evaluation of the tumor marker with exclusion of smokers Cancer 58 1986 1689
48. M.P. Mulder W. Keijzer A. Verkerk Activated ras genes in human seminoma: Evidence for tumor heterogeneity Oncogene 4 1989 1345
49. V.V. Murty G.J. Bosl J. Houldsworth Chaganti RS: Allelic loss and somatic differentiation in human male germ cell tumors Oncogene 9 1994 2245
50. V.V.V.S. Murty R.S.K. Chaganti Allelotyping of male germ cell tumors Am J Hum Genet 49 1991 122
51. V.V.V.S. Murtry J. Houldsworth S. Baldwin Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors Proc Natl Acad Sci U S A 89 1992 11006
52. V.V. Murty R.G. Li R. Mathew Replication error-type genetic instability at 1q 42-43 in human male germ cell tumors Cancer Res 54 1994 3983
53. O.S. Nielsen A.J. Munro W. Duncan Is placental alkaline phosphatase (PLAP) a useful marker for seminoma? Eur J Cancer 26 1990 1049
54. D.C. Olson V. Marechal J. Mornand Identification and characterization of multiple mdm-2 proteins and mdm-2 p53 protein complexes Oncogene 8 1993 2353
55. P. Peltomaki A. Halme A. De La Chapelle Molecular studies of the sex chromosomes in human testicular cancer: Pronounced changes in X and Y chromosome dosage in some tumors Genes Chromosom Cancer 1 1989 42
56. P. Peltomaki R. Lothe A. Borresen Altered dosage of the sex chromosomes in human testicular cancer: A molecular genetic study Int J Cancer 47 1991 518
57. H.Q. Peng D. Hogg D. Malkin Mutations of the p53 gene do not occur in testis cancer Cancer Res 53 1993 3574
58. J.P. Richie Neoplasms of the testis P.C. Walsh A.B. Retik T.A. Stamey Campbell's Urology 6 ed 1992 WB Saunders Philadelphia 1222
59. J.P. Richie Testicular cancer: What staging investigations are indicated? Semin Urol Oncol 14 1996 13
60. M. Ridanpaa R.A. Lothe A. Onfelt K- ras oncogene codon 12 point mutations in testicular cancer Environ Health Perspect 101 Suppl 3 1993 185
61. E. Rodriguez S. Matthew A.B. Mukherjee Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization Genes Chromosom Cancer 5 1992 21
62. E. Rodriguez S. Mathew V. Reuter Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors Cancer Res 52 1992 2285
63. D.B. Rukstalis Molecular mechanisms of testicular carcinogenesis World J Urol 14 1996 347
64. G.J.S. Rustin N.J. Vogelzang D.T. Sleijfer J.N. Nisselbaum Consensus statement on circulating tumour markers and staging patients with germ cell tumours EORTC Genitourinary Group Monograph 7: Prostate Cancer and Testicular Cancer 1990 Wiley-Liss New York 277
65. H. Shimogaki S. Kitazawa S. Maeda S. Kamidono Variable expression of hst-1, int-1 and parathyroid hormone-related protein in different histological types of human testicular germ cell tumors Cancer J 6 1993 81
66. R.J.C. Slebos R.E. Kibbelaar O. Dalesio K- ras oncogene activation as a prognostic marker in adenocarcinoma of the lung N Engl J Med 323 1990 561
67. G.W. Sledge J.N. Eble B.J. Roth Flow cytometry derived DNA content of the primary lesions of advanced germ cell tumors Int J Androl 10 1987 115
68. G.W. Sledge J.N. Eble B.J. Rogh Relation of proliferative activity to survival in patients with advanced germ cell cancer Cancer Res 48 1988 3864
69. R.C. Smith D.B. Rukstalis Frequent loss of heterozygosity at 11p loci in testicular cancer J Urol 153 1995 1684
70. T. Strohmeyer Molecular biologic investigations of proto-oncogenes and growth factors in human testicular tumors World J Urol 12 1994 74
71. T. Strohmeyer M. Fleischhacker Y. Imal Status of the p53 tumor suppressor gene and the mdm-2 gene in human testicular tumors J Urol 149 1993 311A
72. T. Strohmeyer A. Klone G. Wagner Glutathione S-transferase in human testicular germ cell tumors: Changes of expression and activity J Urol 147 1992 1424
73. T. Strohmeyer S. Peter M. Hartman Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors Cancer Res 51 1991 1811
74. T. Strohmeyer D. Reese M. Press Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue J Urol 153 1995 511
75. T. Strohmeyer P. Reissmann C. Cordon-Cardo Correlation between retinoblastoma gene expression and differentiation in human testicular tumors Proc Natl Acad Sci U S A 88 1991 6662
76. T. Tanaka D.J. Slamon H. Battifora M.J. Cline Expression of p21 ras oncoproteins in human cancers Cancer Res 46 1986 1465
77. H. Tesch R. Furbass J. Casper Cellular oncogenes in human teratocarcinoma cell lines Int J Androl 13 1990 377
78. Y. Tsujimoto J. Cossman E. Jaffe C. Croce Involvement of the bcl-2 gene in human follicular lymphoma Science 228 1985 1440
79. T. Ulbright A. Orazi W. DeRiese The relationship of p53, PCNA, and S-phase in non-seminomatous germ cell tumors of the testis [abstract] Lab Invest 68 1993 A71
80. 3]-thymidine labeling index and monoclonal antibody Ki-67 in non-Hodgkins lymphomas Hematol Oncol 6 1988 21
81. K. Vistisen H. Prieme H. Okkels Genotype and phenotype of glutathione S-transferase mu in testicular cancer Pharmacogenetics 7 1997 21 25
82. K.I. Wishnow D.E. Johnson D.A. Swanson Identifying patients with low-risk clinical stage I nonseminomatous testicular tumors who should be treated by surveillance Urology 34 1989 339
83. T. Yoshida M. Tsutsumi H. Sakamoto Expression of the hst-1 oncogene in human germ cell tumors Biochem Biophys Res Commun 155 1988 1324